Side Effect Registry Immuno-Oncology

Side Effect Registry Immuno-Oncology

A global registry for immune‑related adverse events in oncology.
Image
Image
Image
Image
Image
Image
Who we are

As physicians treating cancer patients with immunotherapies, we concentrate on recognising and managing immune-related adverse events (irAEs) arising from treatments such as immune checkpoint inhibitors, CAR-T cell therapies, and bispecific antibodies. We operate the SERIO online registry in partnership with the Paul Ehrlich Institute and collaborate with interdisciplinary irAE specialists worldwide to turn real-world data into safer, more effective care for patients.

17
Tumor Types
1643
Rare and complex cases
101
Collaborating Centres
18
Countries

SERIO aims to help physicians manage side effects and gain better knowledge of side effects induced by immunotherapy.

What we do

Collection
Register and analyze cases of rare, complex, severe and therapy-refractory adverse reactions induced by immunotherapy

Education
Provide physicians with recommendations for the management of immune-related adverse events (irAEs)

Research
Understand irAE pathogenesis to enable prediction of adverse events